Table 2.
Pathological data for patients with hepatitis C-associated hepatocellular carcinoma treated with liver transplantation (LT) or liver resection (LR)
| LT group (n = 52) | LR group (n = 56) | P-value | |
|---|---|---|---|
| Tumour size, cm, mean ± SD | 3.30 ± 1.86 | 3.35 ± 1.31 | 0.871 |
| Tumour number, n (%) | |||
| Solitary | 27 (51.9) | 49 (89.1) | < 0.001 |
| Multinodular | 25 (48.1) | 6 (10.9) | |
| Vascular invasion, n (%) | |||
| None | 30 (57.7) | 22 (40.0) | 0.120 |
| Microscopic | 19 (36.5) | 25 (45.5) | |
| Gross | 3 (5.8) | 8 (14.5) | |
| Satellite nodules, n (%) | 7 (13.5) | 12 (21.8) | 0.258 |
| Differentiation, n (%) | |||
| Good | 17 (32.7) | 15 (27.3) | 0.156 |
| Moderate | 22 (42.3) | 28 (50.9) | |
| Poor | 7 (13.5) | 11 (20.0) | |
| Necrotic (treated) | 6 (11.5) | 1 (1.8) | |
| AJCC TNM stagea, n (%) | |||
| I | 14 (26.9) | 19 (34.5) | 0.451 |
| II | 32 (61.5) | 28 (50.9) | |
| III | 5 (9.6) | 8 (14.5) | |
| IV | 1 (1.9) | 0 | |
| UNOS TNM stagea, n (%) | |||
| I | 6 (11.5) | 3 (5.5) | 0.201 |
| II | 27 (51.9) | 39 (70.9) | |
| III | 8 (15.4) | 4 (7.3) | |
| IV | 11 (21.2) | 9 (16.4) | 0.871 |
a
Based on pathological analysis.
SD, standard deviation; AJCC, American Joint Committee on Cancer; TNM, tumour–node–metastasis; UNOS, United Network for Organ Sharing.